MK
Maneesh Kumar
About Maneesh Kumar
Data last updated:
Maneesh Kumar has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Ciro Medivision Private Limited and Sims Healthtech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Sims Healthtech Private Limited at ₹17 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Jul 2016 | 2016 | ₹17 Lakh (FY 2023) | Active | |
| Director | 18 May 2010 | 2010 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maneesh Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maneesh Kumar
Maneesh Kumar has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Ciro Medivision Private Limited and Sims Healthtech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Sims Healthtech Private Limited at ₹17 Lakh (FY 2023).
Maneesh Kumar is associated with 2 companies as Director, including Sims Healthtech Private Limited (₹17 Lakh), Ciro Medivision Private Limited.
Maneesh Kumar has expertise in General Business, Technology.
Maneesh Kumar has 16 years in corporate governance.
By reported revenue, the largest current company of Maneesh Kumar is Sims Healthtech Private Limited, with revenue of ₹17 Lakh (FY 2023).
Maneesh Kumar currently holds positions at 2 companies: Sims Healthtech Private Limited (₹17 Lakh), Ciro Medivision Private Limited.